Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Orme

Showing results (41-50 of 464) with videos related to

Pageof 47
Sort By:
Clinical and Vaccine Immunology : CVI|December 26, 2014
Tuberculosis vaccine types and timingsIan M Orme
Infection and Immunity|December 1, 1988
Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccinesI M Orme
Journal of Immunology (Baltimore, Md. : 1950)|July 26, 2017
Pillars Article: The Kinetics of Emergence and Loss of Mediator T Lymphocytes Acquired in Response to Infection with <i>Mycobacterium Tuberculosis</i>. <i>J. Immunol</i>. 1987. 138: 293-298Ian M Orme
Vaccine|September 6, 2005
Preclinical testing of new vaccines for tuberculosis: a comprehensive reviewIan M Orme
Tuberculosis (Edinburgh, Scotland)|November 2, 2005
Safety issues regarding new vaccines for tuberculosis, with an emphasis on post-exposure vaccinationIan M Orme
Trends in Microbiology|June 1, 1993
The role of CD8+ T cells in immunity to tuberculosis infectionI M Orme
Kekkaku : [Tuberculosis]|March 21, 2000
Tuberculosis: recent progress in basic immunity and vaccine developmentI M Orme
Anaesthesia|August 25, 1999
Ethical approval for research in anaesthesiaR M Orme
Trends in Microbiology|May 16, 1998
The immunopathogenesis of tuberculosis: a new working hypothesisI M Orme
The American Review of Respiratory Disease|November 1, 1988
Antimycobacterial activity in vivo of LM427 (rifabutin)I M Orme
Pageof 47

Showing results (41-50 of 464) with videos related to

Sort By:
Pageof 47
Clinical and Vaccine Immunology : CVI|December 26, 2014
Tuberculosis vaccine types and timingsIan M Orme
Infection and Immunity|December 1, 1988
Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccinesI M Orme
Journal of Immunology (Baltimore, Md. : 1950)|July 26, 2017
Pillars Article: The Kinetics of Emergence and Loss of Mediator T Lymphocytes Acquired in Response to Infection with <i>Mycobacterium Tuberculosis</i>. <i>J. Immunol</i>. 1987. 138: 293-298Ian M Orme
Vaccine|September 6, 2005
Preclinical testing of new vaccines for tuberculosis: a comprehensive reviewIan M Orme
Tuberculosis (Edinburgh, Scotland)|November 2, 2005
Safety issues regarding new vaccines for tuberculosis, with an emphasis on post-exposure vaccinationIan M Orme
Trends in Microbiology|June 1, 1993
The role of CD8+ T cells in immunity to tuberculosis infectionI M Orme
Kekkaku : [Tuberculosis]|March 21, 2000
Tuberculosis: recent progress in basic immunity and vaccine developmentI M Orme
Anaesthesia|August 25, 1999
Ethical approval for research in anaesthesiaR M Orme
Trends in Microbiology|May 16, 1998
The immunopathogenesis of tuberculosis: a new working hypothesisI M Orme
The American Review of Respiratory Disease|November 1, 1988
Antimycobacterial activity in vivo of LM427 (rifabutin)I M Orme
Pageof 47